ARTICLE | Clinical News
Marimastat: Completed Phase III trials
January 22, 2001 8:00 AM UTC
British Biotech plc (LSE:BBG; BBIOY), Oxford, U.K. Product: Marimastat Business: Cancer Therapeutic category: Metalloproteinase inhibitor Target: Matrix metalloproteinases (MMPs) Description: Oral ma...